Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shuying Ru"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectiveThis meta-analysis aims to assess the efficacy and safety of adding pegylated interferon (Peg-IFN) to long-term nucleos(t)ide analogs (NAs) treatment for achieving functional cure in patients with chronic hepatitis B (CHB).MethodsThis meta-a
Externí odkaz:
https://doaj.org/article/466deaa583fc4833aa14a2769c0af9b9
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0284411 (2023)
BackgroundChronic atrophic gastritis is a significant premalignant lesion of gastric carcinoma. There is a great need to prevent the progression to gastric carcinoma through early intervention and treatment for chronic atrophic gastritis. Weifuchun,
Externí odkaz:
https://doaj.org/article/f43d054c0a99488ba00d285f1227aaf3
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background Ascites is one of the most common complications of cirrhosis. Umbilical therapy with traditional Chinese medicines has been increasingly prescribed to treat cirrhotic ascites. However, high-quality evidence from clinical trials su
Externí odkaz:
https://doaj.org/article/ee478d805c734e2f9af5720d9bece887
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-8 (2019)
Trials
Trials
Background Ascites is one of the most common complications of cirrhosis. Umbilical therapy with traditional Chinese medicines has been increasingly prescribed to treat cirrhotic ascites. However, high-quality evidence from clinical trials supporting
SPIRIT 2013 checklist. (DOC 124 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c60f4f4f5820e2c06274b8202fbcd4b
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2013 (2013)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
ChiCTR-TRC-11001263 study was the first large-scale double-blind randomized placebo-controlled traditional Chinese medicines (TCMs) and adefovir (ADV) antihepatitis B virus (HBV) infection trial in the world. A total of 560 hepatitis B e antigen- (HB
Publikováno v:
Evidence-based Complementary & Alternative Medicine (eCAM); 2013, Vol. 2013, p1-12, 12p, 6 Charts, 7 Graphs